Rigel Pharmaceuticals | RIGL - Рыночная капитализация





Рыночная капитализация Изменить Дата
Agenus USD 107M 16M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.7B 920M 2026-05
AstraZeneca USD 301.25B 13.1B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Celldex Therapeutics USD 2.21B 99M 2026-05
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Halozyme Therapeutics USD 8.56B 905M 2026-05
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
Ligand Pharmaceuticals USD 3.72B 257M 2026-05
MacroGenics USD 102M 4M 2025-12
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Veracyte USD 2.59B 16M 2026-05